Literature DB >> 35450360

Inhibitors of Nav1.7 for the Treatment of Pain.

Benjamin E Blass1.   

Abstract

Entities:  

Year:  2022        PMID: 35450360      PMCID: PMC9014712          DOI: 10.1021/acsmedchemlett.2c00088

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  3 in total

Review 1.  Selective Ligands and Drug Discovery Targeting the Voltage-Gated Sodium Channel Nav1.7.

Authors:  Jian Payandeh; David H Hackos
Journal:  Handb Exp Pharmacol       Date:  2018

2.  The Two Sides of NaV1.7: Painful and Painless Channelopathies.

Authors:  Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

Review 3.  Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7.

Authors:  John V Mulcahy; Hassan Pajouhesh; Jacob T Beckley; Anton Delwig; J Du Bois; John C Hunter
Journal:  J Med Chem       Date:  2019-05-07       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.